News

Glucotrack Secures Ethical Approval for Diabetes Device Study

Glucotrack Secures Ethical Approval for Diabetes Device Study

Ethical Approval Secured for Glucotrack's Clinical Study

Glucotrack, Inc. (NASDAQ: GCTK) has made a significant step in diabetes management by obtaining ethical clearance from the St. Vincent’s Hospital Melbourne Human Research Ethics Committee for its comprehensive clinical study. This innovative study focuses on the long-term use of the Company’s continuous blood glucose monitor (CBGM) in individuals managing type 1 and type 2 diabetes.

Study Overview and Objectives

The long-term, prospective, single-arm, multi-center study aims to recruit up to 30 participants suffering from diabetes mellitus who require consistent glucose monitoring and intensive insulin therapy. Over an initial assessment period of one year, the study will analyze the performance and safety of Glucotrack’s device. The Company plans to submit additional documentation to extend the study's duration to three years following the initial evaluation.

Regulatory Process Following Approval

Now that ethical approval has been granted, Glucotrack will communicate with the Therapeutic Goods Administration (TGA) of Australia, responsible for regulating therapeutic goods, prior to enrolling participants. The commencement of the study is anticipated, with the first implantations expected to take place in July.

Leading Expert Involved in the Study

Distinguished researchers will guide the study under the leadership of Professor David O’Neal, the Director and Founder of the Diabetes Technology Research Group at the University of Melbourne. He will be joined by Associate Professor Neale Cohen from the Baker Heart and Diabetes Institute. Professor O’Neal expressed his enthusiasm regarding the study, stating, "This technology could significantly improve glycemic control, providing diabetes patients with a greater selection in continuous glucose monitoring systems." He highlighted that the potential of measuring blood glucose directly offers a transformational improvement over traditional methods that rely on interstitial fluid measurements.

Innovative Features of Glucotrack’s CBGM

Glucotrack’s CBGM system is designed to ensure user comfort and accuracy by being a long-term implantable device. Unlike conventional glucose monitors that require users to wear an external device, this innovative system provides seamless monitoring for up to three years with minimal calibration needed. Additionally, by directly measuring glucose levels in the blood, it aims to offer real-time insights with reduced lag time compared to previous interstitial fluid methods.

Comments from Leadership

Highlighting the importance of this achievement for Glucotrack, Dr. Paul V. Goode, President and CEO, remarked, "This milestone underscores our commitment to our clinical program and builds on our previous successful trials. Collaborating with leading experts like Professor O’Neal will provide essential information regarding the long-term safety and efficacy of our CBGM system. Taking into account patient feedback, we aim to solve critical challenges in diabetes monitoring, such as sensor lifespan and the removal of on-body components."

Focused on Diabetes Innovation

Glucotrack, Inc. (NASDAQ: GCTK) continues to focus on developing advanced technologies for diabetes care. The CBGM system, with its long-lasting sensor capability and minimal use of external worn devices, promises to deliver a more user-friendly experience for individuals managing diabetes. As the study progresses, anticipation grows regarding the insights it will bring to enhance the lives of those living with diabetes.

Frequently Asked Questions

What is Glucotrack's latest clinical study about?

Glucotrack's latest study focuses on evaluating the long-term performance and safety of its continuous blood glucose monitor for type 1 and type 2 diabetes patients.

How many participants will be enrolled in the study?

The study plans to enroll up to 30 participants who require glucose monitoring as part of their diabetes management.

What is unique about Glucotrack’s glucose monitoring system?

The CBGM measures blood glucose directly, unlike traditional systems that use interstitial fluid, providing real-time and more accurate glucose readings.

When is the expected start date for patient enrollment?

The first implants of the device are expected to begin in July, following the necessary regulatory notifications.

Who is overseeing this clinical trial?

The study will be led by Professor David O’Neal and Associate Professor Neale Cohen, regarded experts in diabetes technology research.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Ontario Airport Braces for Holiday Travel Surge

Updated Category News Views 92

Gearing Up for a Thanksgiving Travel Boom Think Thanksgiving brings only turkey to the table? Down in Ontario, California, it's all about jet fuel and passenger counts. The Ontario International Airport (ONT) is where the skies are buzzing, forecasting over 227,000 passengers trying to soak up the holiday vibes by air. Compare that to the numbers when the local folks...

Continue Reading
LinkedIn Shines: Brands Face Social Media Slump

Updated Category News Views 71

LinkedIn: The Unsung Hero in Social Platforms In a world where social media seems to be as unpredictable as the stock market, LinkedIn is surprisingly holding the line. According to Vista Social's 2027 report, LinkedIn proudly boasts the highest median engagement rate among brand pages at 5.8%. Now, in the wild west of social media, where reach is getting tougher to snag,...

Continue Reading
First Time Homebuyer Tips for Southern Maryland Success

Updated Category News Views 54

Shaking Up First-Time Homebuyer Assumptions Ever hear that age-old nonsense about needing a fat stack of cash as a down payment before you can snag your first home? Yeah, turns out that's about as outdated as a rotary phone. Robin Cavallaro from RE/MAX Realty Group in Annapolis is setting the record straight for first-time buyers in Southern Maryland. Down Payment Myths...

Continue Reading
HLTH USA 2026 Spotlights AI and Health Innovation

Updated Category News Views 77

The Pulse of Innovation at HLTH USA 2026 Diving headfirst into the heart of healthcare innovation, HLTH USA 2026 kicked off with gusto in Las Vegas. Discussions are swirling around AI advancements and the next generation of payer-provider collaboration. Who knew healthcare could be this thrilling? The event is already shaping up to be a powerhouse of change, buzzing with...

Continue Reading
Bacterial Breakthrough in Cancer Therapy: Game Changer?

Updated Category News Views 60

Blurring Lines Between Bugs and Biotech Well, wouldn't you know it, the eggheads over at Jeonbuk National University in South Korea are at it again, pushing the boundaries of what these little bacterial buggers can do. This time, they’ve had a crack at cancer therapy, using engineered Salmonella to pack a double punch against breast cancer in mice. Now, if that ain't...

Continue Reading
Tigo Energy Faces Lawsuit: Key Details for Investors

Updated Category News Views 89

Tigo Energy Inc.'s Troubles: A Stock Drop and Legal Woes You see, not every day do you wake up to find your investment taking a nose dive by 36.76%. But that’s exactly what happened to Tigo Energy, Inc. (NASDAQ: TYGO) after some shaky announcements. A Rollercoaster for Investors On August 4, 2026, Tigo hit investors with a one-two punch: revised financial outlook and...

Continue Reading
Rock Tech Uncovers Major Lithium Discovery at Victory

Updated Category News Views 84

Rock Tech's Game-Changer at Victory Folks, we've got a shake-up in the lithium landscape over in Ontario, courtesy of Rock Tech Lithium Inc. They just unearthed something quite promising at their Victory Project: a spanking new spodumene-bearing pegmatite discovery. Now I know, if you're like me, you're thinking, 'What's the angle here?' Well, this isn't just another hole...

Continue Reading
Pine Tree Bets Big on Tulsa Hills Shopping Center

Updated Category News Views 152

Pine Tree's Latest Move in Retail Real Estate Ya ever watch a company make a move so aligned with its playbook that it feels like a script straight outta the boardroom? That's Pine Tree with its recent snag of Tulsa Hills Shopping Center for a cool $108 million. This ain't just any retail spot; it's a bustling hub nestled within the posh outskirts of Jenks, Oklahoma....

Continue Reading
Kansai Powers Up US Grid with Bold Investment Move

Updated Category News Views 99

Betting Big on Battery Storage Let's unpack this big move by Kansai Electric. Anytime a major player like Kansai steps out of its home turf, folks better pay attention. Looks like Kansai's gotten cozy with Elevate and ArcLight, nabbing a minority stake in Prospect Power. This ain't your average widget factory—it's a beefy 150MW/600MWh battery energy storage facility in...

Continue Reading
Segway Powersports Dominates Baja 1000 with Class 2 Sweep

Updated Category News Views 109

Catching the eye of any betting man, Segway Powersports has turned its maiden outing at the relentless SCORE Baja 1000 into a rousing victory. Their arrival on this unforgiving stage with a one-two in Class 2 isn't just a lucky roll—you don't chance upon podium sweeps in such gritty contests. Dissecting the Drive: Commitment and Coordination Unfolding across Baja's...

Continue Reading

Top 5 Most Recently Viewed Articles

Algeness® VL Filler Receives Marketing Approval in China

Updated Category News Views 273

Exciting Developments for Advanced Aesthetic Technologies Advanced Aesthetic Technologies, Inc. (AAT) recently celebrated a significant milestone with the approval of their Algeness® VL agarose facial injection filler for marketing in China. This landmark achievement opens up new avenues for AAT in expanding their product offerings in the Asian market and showcases their...

Continue Reading
Criminal Charges Anticipated in Trump Campaign Hacking Case

Updated Category News Views 154

Criminal Charges Expected in Trump Campaign Hacking Case U.S. authorities are preparing to file criminal charges regarding an incident in which the Trump campaign claimed its internal communications were hacked, allegedly by the Iranian government. This concerning situation has drawn the attention of both the public and officials, raising serious issues surrounding...

Continue Reading
Semler Scientific Faces Class Action Lawsuit: What Investors Need to Know

Updated Category News Views 187

Semler Scientific and the Class Action Lawsuit Overview In recent news, a class action lawsuit has taken center stage involving Semler Scientific, Inc. (SMLR). Investors who have experienced losses related to their investments in Semler are advised to take note of this development, which may directly impact their financial outcomes. Understanding the Lawsuit This class...

Continue Reading
FTC Solar Engages Investors at Key Industry Conferences

Updated Category News Views 159

FTC Solar Engages Investors at Key Industry Conferences FTC Solar, Inc. (Nasdaq: FTCI), an innovative leader in solar tracker systems and engineering services, is set to make significant strides in connecting with investors at three prominent conferences. These events provide a platform for the management team, including CEO Yann Brandt, to engage in discussions that...

Continue Reading
Anixa Biosciences Set to Share Innovations in Cancer Therapy

Updated Category News Views 88

Anixa Biosciences Set to Conduct a Notable Presentation Anixa Biosciences, Inc. (NASDAQ: ANIX), a leading biotechnology firm dedicated to the treatment and prevention of cancer, has taken a significant step forward by announcing its participation in a prestigious investment conference. This event, the H.C. Wainwright 27th Annual Global Investment Conference, promises to...

Continue Reading